Showing results (801-810 of 1,028) with videos related to

Sort By:
Pageof 103
The Journal of Infectious Diseases|February 7, 2018
Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster VaccineMyron J Levin, Guang-Yun Cai, Katherine S Lee, et al.
Nephron|January 1, 1981
Iron absorption in patients on regular dialysis therapyW R Bezwoda, D P Derman, T H Bothwell, et al.
Social Work in Health Care|January 1, 1990
Empowering families of the chronically ill: a partnership experience in a hospital settingJ B Mayer, L R Kapust, A L Mulcahey, et al.
The Medical Journal of Australia|February 5, 2008
The prevention and management of herpes zosterAnthony L Cunningham, Judith Breuer, Dominic E Dwyer, et al.
Plos One|May 23, 2015
Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case reviewChristiana Smith, Jeri E Forster, Myron J Levin, et al.
Steroids|December 1, 1990
Follicular-phase serum progesterone levels of nonsmoking women do not differ from the levels of nonsmoking menB Zumoff, L Miller, J Levin, et al.
Vaccine|January 31, 2012
Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective studyMélanie Drolet, Myron J Levin, Kenneth E Schmader, et al.
AIDS (London, England)|October 3, 2003
Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected childrenStuart E Starr, Elizabeth J McFarland, Petronella Muresan, et al.
The New England Journal of Medicine|April 27, 1978
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexesF Koster, J Levin, L Walker, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study GroupJ R Groothuis, M J Levin, W Rodriguez, et al.
Pageof 103